Xinzhou Li, 10% Owner at NovaBay Pharmaceuticals, Inc. (NBY), bought 800,000 shares at $1.25 ($1.0M) on 2012-09-13, disclosed to the SEC on 2013-01-02.
Open-market purchase of $1.0M NBY by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| NBY | BUY | 2013-01-02 | $1.5M | — | Filing → |